Thomas C. K. Yuen

Insider Reports History

Entity
Individual
Signature
/s/ Thomas C.K. Yuen
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas C. K. Yuen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PharmaCyte Biotech, Inc. Director Common Stock 1.67K Aug 10, 2021 Direct

Insider Reports Filed by Thomas C. K. Yuen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PMCB PharmaCyte Biotech, Inc. Aug 10, 2021 0 $0 3 Aug 31, 2021 Director